Weiguo Zhang

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 3

Top Topics

Tyrosine Kinase

Anti Inflammatory

Extracorporeal Membrane Oxygenation

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Research square

This page only lists publications with an associated author ORCID identifier.

Publications

Guopan Yu, Weiguo Zhang, Hongying Zhang, Charlie Ly, Mahesh Basyal, William G Rice, Michael Andreeff
The multi-kinase inhibitor CG-806 exerts anti-cancer activity against acute myeloid leukemia by co-targeting FLT3, BTK, and Aurora kinases. Research square (2023)
Guopan Yu, Weiguo Zhang, Hongying Zhang, Charlie Ly, Mahesh Basyal, William G Rice, Michael Andreeff
The multi-kinase inhibitor CG-806 exerts anti-cancer activity against acute myeloid leukemia by co-targeting FLT3, BTK, and Aurora kinases. Research square (2023)
Guopan Yu, Weiguo Zhang, Hongying Zhang, Charlie Ly, Mahesh Basyal, William G Rice, Michael Andreeff
The multi-kinase inhibitor CG-806 exerts anti-cancer activity against acute myeloid leukemia by co-targeting FLT3, BTK, and Aurora kinases. Research square (2023)